3-4313174-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000358065.5(SETMAR):āc.433A>Gā(p.Lys145Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000173 in 1,614,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000358065.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SETMAR | NM_006515.4 | c.433A>G | p.Lys145Glu | missense_variant | 2/3 | ENST00000358065.5 | NP_006506.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SETMAR | ENST00000358065.5 | c.433A>G | p.Lys145Glu | missense_variant | 2/3 | 1 | NM_006515.4 | ENSP00000373354 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251252Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135796
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461754Hom.: 0 Cov.: 33 AF XY: 0.0000220 AC XY: 16AN XY: 727180
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152316Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74476
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | The c.433A>G (p.K145E) alteration is located in exon 2 (coding exon 2) of the SETMAR gene. This alteration results from a A to G substitution at nucleotide position 433, causing the lysine (K) at amino acid position 145 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at